98%
921
2 minutes
20
Background: Primary insomnia (PI) is a prevalent sleep disorder that significantly impacts quality of life. While pharmacological treatments are common, concerns about side effects and dependency have led to increased interest in non-pharmacological alternatives. This study systematically evaluates the efficacy and safety of various non-pharmacological therapies for adult PI through a network meta-analysis, providing evidence-based guidance for clinicians.
Methods: We analyzed 53 randomized controlled trials (RCTs) involving 4,181 adults with PI. The included studies assessed 11 non-pharmacological interventions, such as acupuncture, acupressure, cupping therapy, and cognitive behavioral therapy (CBT), alongside control groups (e.g., placebo, waitlist, and pharmacological comparators). Primary outcomes included the Pittsburgh Sleep Quality Index (PSQI), total sleep time (TST), sleep efficiency (SE), and sleep latency (SL). Data synthesis was performed using STATA 17 software with a random-effects model, and evidence quality was appraised using the GRADE framework.
Results: Pooled analyses revealed that all seven non-pharmacological therapies significantly improved PI outcomes compared to controls. Acupuncture reduced PSQI scores by -2.71 points (95% confidence interval (CI): -4.94 to -0.49) versus waitlist, while acupuncture showed a - 1.81 point reduction (95% CI: -2.93 to -0.68). For SE, acupressure and CBT increased SE by 1.48% (95% CI: 0.56-2.39) and 1.34% (95% CI: 0.70-1.98), respectively, compared to SH. Notably, CBT and acupressure shortened SL by approximately 10 min (e.g., CBT: -10.15 min, 95% CI: -11.79 to -8.52 vs. benzodiazepines), while acupressure extended TST by 2.07 h (95% CI: 0.46-3.68). SUCRA rankings identified CBT as the most effective for reducing SL (85.8% probability) and improving SE (89.2%), whereas acupuncture excelled in increasing TST (84.8%). Adverse events were infrequent and mild, primarily limited to transient localized reactions in acupuncture studies.
Conclusion: This study demonstrates that non-pharmacological therapies are effective and safe in managing PI, with CBT, acupuncture, and acupressure emerging as optimal choices for specific sleep parameters. These findings advocate non-pharmacological interventions into clinical practice and offer clinicians valuable insights for selecting appropriate treatment modalities for PI management. However, study limitations like heterogeneity and small sample sizes highlight the need for larger, well-designed RCTs. Future studies should use standardized measures for more specific insomnia assessment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344310 | PMC |
http://dx.doi.org/10.3389/fneur.2025.1607903 | DOI Listing |
Croat Med J
August 2025
Ezgi Mutluay Yayla, Health Sciences Faculty, Tarsus University, 33400 Mersin, Turkey,
Aim: To systematically review randomized controlled trials evaluating the efficacy of sleep-oriented non-pharmacological interventions for delirium prevention in intensive care units.
Methods: We searched PubMed, Web of Science, Scopus, and the Cochrane Library for randomized controlled trials evaluating the efficacy of sleep-oriented, non-pharmacological interventions for delirium prevention in intensive care units published in English between 2019 and 2024. The methodological quality of the included studies was independently evaluated by two researchers using the Joanna Briggs Institute tool.
Expert Rev Neurother
September 2025
Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital incorporating the National Children's Hospital (AMNCH), Dublin, Ireland.
Introduction: Refractory migraine (RM) is characterized by a lack of response to both migraine-specific and repurposed treatments, significantly impairing quality of life. Risk factors for RM include, among others, overuse of symptomatic medications, nonadherence to treatment and comorbid conditions that limit the use of anti-migraine medications.
Areas Covered: This critical perspective addresses the diagnosis and management of patients with RM.
Phytomedicine
August 2025
Laboratory of Neurological Disease Modeling and Translational Research, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address:
Background: Stress is a prevalent mental health concern that often emerges in late adolescence or early adulthood. Since 2007, the Food and Drug Administration (FDA) has not approved any novel anxiolytic pharmaceuticals, leading to increased interest in nutritional supplements as alternative therapies for stress management.
Purpose: Building on our previous study, this work aims to investigate the synergistic effects of Theanine (Th) and Walnut Peptide (WP) on stress mitigation and cognitive enhancement.
J Nephrol
September 2025
Italian Society of General Medicine (SIMG), COMEGEN Primary Care Physicians Cooperative, Naples, Italy.
Background: Kidney stone formation is driven by an imbalance between lithogenic substances and crystallization inhibitors. Current guidelines recommend a 24-h urine collection in patients with kidney stone disease to assess the risk of stone formation and monitor therapy compliance. However, real-world data on adherence to these guidelines remain limited and outdated.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Older Person Medical Clinic, Suite 3/18 Lambton Road, Broadmeadow, New South Wales, 2292, Australia.
Sleep and circadian disturbances are prevalent in Parkinson's disease (PD) and become increasingly complex in older adults, where aging-related changes, comorbidities, and polypharmacy further disrupt sleep. This review explores the pathophysiology of sleep and circadian dysfunction in aging and PD, highlighting the impact of neurodegenerative changes and neurotransmitter dysregulation. Key sleep disorders in older adults with PD are discussed with a focus on their epidemiology, assessment, and tailored management.
View Article and Find Full Text PDF